Our providers collaborate with radiation oncology, surgical oncology, and health care providers of Inspira Health Network under one roof at the Frank and Edith Scarpa Regional Cancer Pavilion to improve multidisciplinary cancer services across Southern New Jersey.

Southern Oncology Hematology Associates is proud to be involved in the community we serve. Our providers are always available to local clubs, associations and community organizations educating their members regarding recent updates in the field of oncology and hematology.

Upcoming Talks by our providers:
Please email to info@southernoncology.net to schedule a talk by one of our providers for your organization.

Southern Oncology Hematology Associates is the proud sponsor of Survivor’s Dinner at American Cancer Society’s Relay for Life of Cumberland, NJ for the past several years.

Every year, “Team SOHA” participates in the event with full enthusiasm creating awareness and raising funds for the American Cancer Society.

Join our team or support by making donations at:
https://secure.acsevents.org/site/SPageServer/?pagename=relay_donate_now&FR_ID=91145
&_ga=2.91246874.1253651414.1556048993-753486980.1556048993

26

Our Doctors Are Committed to

  • Providing world-class care closer to home
  • Conducting cutting-edge research studies
  • Mentoring young trainees to become great physicians
TITLE: Cost Reduction with Enoxaparin Vs. Heparin for Prophylactic and Therapeutic Use: A Retrospective Analysis in a Community Hospital Setting. Publication Number: 2090 Submission-ID: 106987
In addition to the presentation, abstract will also be published online in the December 8 supplemental volume of Blood http://www.bloodjournal.org/.

SOHA in Local News/Media:

We congratulate Dr. Harry Menon, a resident under the mentorship of Dr. Omar Al Ustwani in Vineland getting accepted to present research data at the elite American Society of Hematology annual meeting http://www.hematology.org/Annual-Meeting/. The researchers meet at this conference to present and discuss cutting-edge data in hematology and hematologic malignancies. This research focuses on improving the strategies of preventing blood clots in the hospital system.